510(k) K092603
K092603 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "COBAS INTEGRA GLUCOSE HK GEN 3 ASSAY". The FDA issued a decision of Substantially Equivalent on December 4, 2009. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Roche Diagnostics has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 4, 2009
- Date Received
- August 25, 2009
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hexokinase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type